![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Suhlrie, Adriana; Hennies, Imke; Gellermann, Jutta; Buescher, Anja; Hoyer, Peter; Waldegger, Siegfried; Wygoda, Simone; Beetz, Rolf; Lange-Sperandio, Baerbel; Klaus, Guenter; Konrad, Martin; Holder, Martin; Staude, Hagen; Rascher, Wolfgang; Oh, Jun; Pape, Lars; Toenshoff, Burkhard und Haffner, Dieter
(2020):
Twelve-month outcome in juvenile proliferative lupus nephritis: results of the German registry study.
In: Pediatric Nephrology, Bd. 35, Nr. 7: S. 1235-1246
Gross, Oliver; Toenshoff, Burkhard; Weber, Lutz T.; Pape, Lars; Latta, Kay; Fehrenbach, Henry; Lange-Sperandio, Baerbel; Zappel, Hildegard; Hoyer, Peter; Staude, Hagen; König, Sabine; John, Ulrike; Gellermann, Jutta; Hoppe, Bernd; Galiano, Matthias; Hoecker, Britta; Ehren, Rasmus; Lerch, Christian; Kashtan, Clifford E.; Harden, Markus; Boeckhaus, Jan und Friede, Tim
(2020):
A multicenter, randomized, placebo -controlled, double-blind phase 3 trial with open -arm comparison indicates safety and ef fi cacy of nephroprotective therapy with ramipril in children with Alport ? s syndrome see commentary.
In: Kidney International, Bd. 97, Nr. 6: S. 1275-1286
Boeckhaus, Jan; Hoefele, Julia; Riedhammer, Korbinian M.; Tonshoff, Burkhard; Ehren, Rasmus; Pape, Lars; Latta, Kay; Fehrenbach, Henry; Lange-Sperandio, Baerbel; Kettwig, Matthias; Hoyer, Peter; Staude, Hagen; Konrad, Martin; John, Ulrike; Gellermann, Jutta; Hoppe, Bernd; Galiano, Matthias; Gessner, Michaela; Pohl, Michael; Bergmann, Carsten; Friede, Tim und Gross, Oliver
(2020):
Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial.
In: Clinical Genetics, Bd. 99, Nr. 1: S. 143-156
Benz, Marcus R.; Ehren, Rasmus; Kleinert, Daniela; Müller, Carsten; Gellermann, Jutta; Fehrenbach, Henry; Schmidt, Heinrich und Weber, Lutz T.
(2019):
Generation and Validation of a Limited Sampling Strategy to Monitor Mycophenolic Acid Exposure in Children With Nephrotic Syndrome.
In: Therapeutic Drug Monitoring, Bd. 41, Nr. 6: S. 696-702